InvestorsHub Logo
Post# of 251889
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 191207

Wednesday, 05/13/2015 4:01:02 PM

Wednesday, May 13, 2015 4:01:02 PM

Post# of 251889
FDA-approved non-tyrosine-kinase inhibitor and their targets

Sorafenib - RAS/RAF
Temsirolimus and Everolimus - mTOR
Vemurafenib and Dabrafenib - B-Raf
Trametinib - Mek
Palbociclib - CDK

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.